Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 452

1.

Pneumocystis pneumonia in solid organ transplant recipients: not yet an infection of the past.

Wang EH, Partovi N, Levy RD, Shapiro RJ, Yoshida EM, Greanya ED.

Transpl Infect Dis. 2012 Oct;14(5):519-25. doi: 10.1111/j.1399-3062.2012.00740.x. Epub 2012 May 10.

PMID:
22571389
2.

Risk factors for Pneumocystis jirovecii pneumonia in kidney transplant recipients and appraisal of strategies for selective use of chemoprophylaxis.

de Boer MG, Kroon FP, le Cessie S, de Fijter JW, van Dissel JT.

Transpl Infect Dis. 2011 Dec;13(6):559-69. doi: 10.1111/j.1399-3062.2011.00645.x. Epub 2011 Jun 21.

PMID:
21689251
3.

Pneumocystis jirovecii pneumonia in renal transplant recipients: a national center experience.

Borstnar S, Lindic J, Tomazic J, Kandus A, Pikelj A, Prah J, Skvarc M, Godnov U, Kovac D.

Transplant Proc. 2013 May;45(4):1614-7. doi: 10.1016/j.transproceed.2013.02.107.

PMID:
23726632
4.

Pneumocystis jirovecii pneumonia is rare in renal transplant recipients receiving only one month of prophylaxis.

Anand S, Samaniego M, Kaul DR.

Transpl Infect Dis. 2011 Dec;13(6):570-4. doi: 10.1111/j.1399-3062.2011.00692.x. Epub 2011 Nov 17.

PMID:
22093215
5.

Risk factors for Pneumocystis carinii pneumonia in kidney transplant recipients: a case-control study.

Radisic M, Lattes R, Chapman JF, del Carmen Rial M, Guardia O, Seu F, Gutierrez P, Goldberg J, Casadei DH.

Transpl Infect Dis. 2003 Jun;5(2):84-93.

PMID:
12974789
6.

Risk factors of Pneumocystis pneumonia in solid organ recipients in the era of the common use of posttransplantation prophylaxis.

Iriart X, Challan Belval T, Fillaux J, Esposito L, Lavergne RA, Cardeau-Desangles I, Roques O, Del Bello A, Cointault O, Lavayssière L, Chauvin P, Menard S, Magnaval JF, Cassaing S, Rostaing L, Kamar N, Berry A.

Am J Transplant. 2015 Jan;15(1):190-9. doi: 10.1111/ajt.12947. Epub 2014 Dec 12.

7.

Pneumocystis jirovecii pneumonia in kidney transplantation.

Goto N, Oka S.

Transpl Infect Dis. 2011 Dec;13(6):551-8. doi: 10.1111/j.1399-3062.2011.00691.x. Epub 2011 Oct 31. Review.

PMID:
22093172
8.

A Pneumocystis jirovecii pneumonia outbreak in a single kidney-transplant center: role of cytomegalovirus co-infection.

Pliquett RU, Asbe-Vollkopf A, Hauser PM, Presti LL, Hunfeld KP, Berger A, Scheuermann EH, Jung O, Geiger H, Hauser IA.

Eur J Clin Microbiol Infect Dis. 2012 Sep;31(9):2429-37. doi: 10.1007/s10096-012-1586-x. Epub 2012 Mar 9.

PMID:
22402816
9.

Late-onset Pneumocystis jirovecii pneumonia in solid organ transplant recipients.

Perez-Ordoño L, Hoyo I, Sanclemente G, Ricart MJ, Cofan F, Perez-Villa F, de la Bellacasa JP, Moreno A, Cervera C.

Transpl Infect Dis. 2014 Apr;16(2):324-8. doi: 10.1111/tid.12184. Epub 2014 Jan 24.

PMID:
24456244
10.

Should prophylaxis for Pneumocystis carinii pneumonia in solid organ transplant recipients ever be discontinued?

Gordon SM, LaRosa SP, Kalmadi S, Arroliga AC, Avery RK, Truesdell-LaRosa L, Longworth DL.

Clin Infect Dis. 1999 Feb;28(2):240-6.

12.

Outbreak of Pneumocystis jiroveci pneumonia in renal transplant recipients: P. jiroveci is contagious to the susceptible host.

Yazaki H, Goto N, Uchida K, Kobayashi T, Gatanaga H, Oka S.

Transplantation. 2009 Aug 15;88(3):380-5. doi: 10.1097/TP.0b013e3181aed389.

PMID:
19667941
13.

Impact of valganciclovir prophylaxis on the development of severe late-cytomegalovirus disease in high-risk solid organ transplant recipients.

Cervera C, Pineda M, Linares L, Marcos MA, Esteva C, Antón A, Cofán F, Ricart MJ, Navasa M, Pérez-Villa F, Pumarola T, Moreno A.

Transplant Proc. 2007 Sep;39(7):2228-30.

PMID:
17889146
14.

Trimethoprim-sulfamethoxazole prophylaxis for Pneumocystis carinii infections in heart-lung and lung transplantation--how effective and for how long?

Kramer MR, Stoehr C, Lewiston NJ, Starnes VA, Theodore J.

Transplantation. 1992 Mar;53(3):586-9.

PMID:
1549851
15.

Nocardia infection in lung transplant recipients.

Husain S, McCurry K, Dauber J, Singh N, Kusne S.

J Heart Lung Transplant. 2002 Mar;21(3):354-9.

PMID:
11897524
16.

Aerosolized pentamidine prophylaxis for Pneumocystis carinii pneumonia after allogeneic marrow transplantation.

Marras TK, Sanders K, Lipton JH, Messner HA, Conly J, Chan CK.

Transpl Infect Dis. 2002 Jun;4(2):66-74.

PMID:
12220242
17.

Prevention of Pneumocystis carinii pneumonia in cardiac transplant recipients by trimethoprim sulfamethoxazole.

Olsen SL, Renlund DG, O'Connell JB, Taylor DO, Lassetter JE, Eastburn TE, Hammond EH, Bristow MR.

Transplantation. 1993 Aug;56(2):359-62.

PMID:
8356591
18.

Absence of Pneumocystis jiroveci pneumonia in liver transplantation recipients receiving short-term (3-month) prophylaxis.

Trotter JF, Levi M, Steinberg T, Lancaster J.

Transpl Infect Dis. 2008 Oct;10(5):369-71. doi: 10.1111/j.1399-3062.2008.00318.x. Epub 2008 May 15.

PMID:
18482201
19.

Atovaquone versus trimethoprim-sulfamethoxazole as Pneumocystis jirovecii pneumonia prophylaxis following renal transplantation.

Gabardi S, Millen P, Hurwitz S, Martin S, Roberts K, Chandraker A.

Clin Transplant. 2012 May-Jun;26(3):E184-90. doi: 10.1111/j.1399-0012.2012.01624.x. Epub 2012 Apr 8.

PMID:
22487221
20.

Pneumocystis jirovecii pneumonia in renal transplant recipients occurring after discontinuation of prophylaxis: a case–control study.

De Castro N, Xu F, Porcher R, Pavie J, Molina JM, Peraldi MN.

Clin Microbiol Infect. 2010 Sep;16(9):1375-7. doi: 10.1111/j.1469-0691.2009.03143.x.

Items per page

Supplemental Content

Write to the Help Desk